Enterprise League logo

Biotechnology Companies in Europe

Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. The directory currently holds 480 companies in this sector. The largest share of listings is based in London. Related sectors on Enterprise League include Medical Equipment and Services, Life Science, Genetics, Pharmaceutical, Biopharma, Clinical Trials, Nanotechnology.
480 companies
London top city

Europe
Biotechnology
List of Biotechnology companies in Europe

480 companies

Sort by

Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
Health Centers
Health and Medical Products
Biopharma
Nanotechnology
Biotechnology
Genetics

2005

PathoQuest helps biopharmaceutical developers and manufacturers get their therapies to market with our leading expertise in GMP NGS-based biosafety testing and characterization services. As innovator companies continue to bring exciting novel therapies to market, there is a critical need for alternative biosafety and characterization strategies. This is especially the case for life-changing cell and gene therapies, as well as novel viral vaccines. Classical testing approaches, such as cell based assays, are often challenging to implement due to high volume requirements, as well as compatibility issues. Biosafety testing and characterization are key regulatory requirements for the release of biologic therapies. Therefore, alternative methods which can address these issues are of intense interest. There is also a drive from across industry and regulators to reduce, and eventually eliminate the use of animal models used in biosafety testing. The genomic approach of Next Generation Sequencing (NGS) can solve many of the challenges that are faced by developers and manufacturers, such as lower volume requirements and incompatibility with cell-based assays From our origins within the Institut Pasteur, PathoQuest is leading the way in expertise for the provision of GMP NGS based biosafety testing. Our expertise is underlined with over 20 peer reviewed publications on NGS applications in biosafety testing; as well as active participation in industry groups such as PDA, ADVTIG, CAACB and EFPIA. PathoQuest are committed to bringing this game-changing genomic approach to biopharmaceutical developers and manufacturers. PathoQuest has a global footprint, with operations in Europe (Paris) and North America (Wayne, PA); and have provided NGS biosafety testing services to over 100 of the top biopharmaceutical companies globally. Why not get in touch to see how we can help you with your biosafety testing strategy?
Healthcare
Biotechnology
Therapeutics

2010

Semarion is a spin-out from Cambridge University with a mission to accelerate the pace of drug discovery. We are revolutionising adherent cell screening to produce better data, faster. Our proprietary SemaCyte® cell microcarrier platform leverages novel materials physics to deliver assay flexibility, miniaturisation, and multiplexing with existing tools and workflows. Our microcarriers function as ultra-miniaturized, magnetically steerable wells which can carrier small colonies of cells to enable more powerful assaying workflows and new experimental paradigms.
Biotechnology

2018

traceless materials is a circular bioeconomy start-up offering a holistically sustainable alternative to plastics and bioplastics. With our first-of-a-kind biomaterial it’s our mission to contribute to solving global plastic pollution. Our innovative technology filed for patent allows to use food production residues to produce materials that are compostable under natural composting conditions. While bio-based, our materials don’t compete with food nor cause land-use-change, don’t need hazardous additives or solvents and have up to 87% lower CO2 emissions. Already competitive in quality, on industrial production scale they’ll be price competitive to virgin plastic in the EU. And since our materials are neither chemically modified nor synthetically polymerized, they will not fall under the EU Plastic Directive. Follow us on our journey, and become a part of the solution, not the pollution!
Biotechnology

2020

Transine Therapeutics is a private biotechnology company, headquartered in Cambridge-UK, focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. Transine® pioneering technology is expected to offer an entirely unique mechanism of action for currently hard-to-treat diseases by massively extending the druggable proteome, enabling it to address diseases which have been beyond the reach of small molecules, conventional biologics or gene therapies.
Biotechnology

2020

TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
Biotechnology

2018

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
Biotechnology

1998

BlueGnome is a specialist supplier of products from the investigation of genetic abnormalities associated with developmental delay, cancer and infertility. BlueGnome’s 24sure technology is widely used by IVF centers to selectively implant chromosomally normally embryos and so improve IVF rates. BlueGnome is a winner of the Queens Award for Innovation and has won multiple awards as one of the UK’s fastest growing biotechs.
Medical
Healthcare
Biotechnology

2002

Our mission is to provide affordable carbon capture on an industrial scale by harnessing genetically modified cyanobacteria. We envision a solution to be at the centre of the global roadmap towards achieving 'Net Zero' by 2050. Enquiries: David.kim@cyanocapture.com (CEO)
Biotechnology

2021

CopperTree Forensics Ltd produce compact, practical Forensic Laser and LED Systems, which detect latent fingerprints, sweat, urine, saliva, blood, and other biological traces during fluorescent examination. Our development programme is in collaboration with UK Law Enforcement and Forensic Services, to achieve first class products that meet the Laser and LED requirements in the field and the Lab. We will continue to develop innovative and ground breaking products to meet the needs of those involved in criminal investigation. CopperTree Forensics also work very closely with UK Universities and the Home Office for testing and ongoing research for “in the field scenarios” using our range of wavelength capabilities. It’s a constant challenge for law enforcement agencies to stay ahead of criminal activity and technological developments. Coupled with greater forensic awareness and the challenge of budget cuts shrinking resources, it has never been more important for companies like CopperTree Forensics to provide the support and products required for the fight against crime. In addition, we offer a full range of services to further assist our customers. Our technically trained team can advise and support your ongoing requirements. We are dedicated to adding value by combining superior technology with unparalleled support. Whilst also providing bespoke systems and OEM for partners worldwide. The commitment to customer care and attention to detail means we are constantly looking to develop and supply the best equipment possible to assist customers in the never ending fight against crime.
Biotechnology

2016

a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of Molecular Biotechnology, Vienna, Austria. a:head applies these complex 3D tissue cultures for modelling of various brain disorders in a human context and aims at translating the technology into a powerful high content, high throughput phenotyping platform for the development of novel CNS therapeutics.
Manufacturing
Pharmaceutical
Biotechnology

2019

SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.
Medical
Healthcare
Biotechnology
Therapeutics

2010

Affordable and clean technology for extending the shelf life of fruits and vegetables in developing counties. Smallholder farmers are the backbone of the economy in developing countries, of which woman carry more than their share. Their success or failure means the difference between eating and NOT eating for over 870 million people who are food insecure around the world. Smallholder farmers face an unsustainably high percentage of losses each and every year. According to the FAO, 45% of fruits and vegetables in developing countries never reach the consumer. That’s 45% less food in markets, on tables and in mouths. This postharvest loss is a result of smallholder farmers lacking adequate protection for their produce from the climate, pests and diseases. Nearly half of their investment of time and resources is needlessly wasted, resulting in higher prices for the entire population. “Improving the productivity, profitability, and sustainability of smallholder farming is the main pathway out of poverty in using agriculture for development.” Kofi Annan Reducing post-harvest losses is the most effective and sustainable solution to hunger and food insecurity. Wakati is a simple and innovative solution that alters the climate of fruit and vegetable storage spaces to increase shelf life and reduce post-harvest losses by over 20 percent. The climate control approach used by Wakati is a affordable and clean-technology. This life changing alternative increase the income by providing better quality and more crops by lowering the losses while the extended shelf live provides more time for growing crops, getting them on the marketplace and a better bargaining position to the local wholesalers.
Industrial Services
Biotechnology
Commercial
Agriculture

2013

Hello Earth. This is Fermify. We are here to domesticate microorganisms and build super simple and fully automated production platform to address the issue of large scale milk protein production. Since we are all mad scientist -and scientist are know as the worst salespeople on this planet- we would love to hear from you if you are a cheese manufacturing company and want to produce cheese with state-of-art technology -without the cow! Please also reach out if you want to join our team. We promote self-growth and enable an environment free from unkindness and fear. Yours, Fermify
Biotechnology

2021

Xegen is a bioinformatics company specialized in Next Generation Sequencing (NGS) data analysis. We provide support for our customers or partners in their NGS data processing issues, through specific, automated, high added value bioinformatics analyzes. Xegen is developing Polypheme a bioinformatics suite dedicated to complex genes analysis (polymorphisms detection or allelic types). Polypheme analysis includes in particular HLA Typing, classic (HLA-A, -B, -C, DRB1, DQB1) and not classic genes (HLA-E, -F, -G, -H). Polypheme is also used to discover new alleles.
Biotechnology

2012

TIGERQ is a Cancer Genomics Software startup in Lund, Sweden. We are commercializing a patented and extremely accurate sequencing analysis for currently unaddressed complex genetic changes (which drive 73% of all cancers), applicable to a €2.8B cancer genomic software market.
Biotechnology

2018

LentiStem is R&D medical biotechnology company which develops platforms for improving safety and efficacy of advanced therapies and CAR-T cells.
Biotechnology

2016

ArgusEye provides innovative sensor systems based on nanoplasmonic detection for real-time monitoring of biological systems and processes.
Biotechnology

2017

We are providing electronically activated purification of biomolecules for biopharmaceutical and protein production. By utilizing our patent-pending invention, we build functionalized polymer surfaces that can with high specificity and high capacity capture and release biomolecules at the press of a button. Making today's complex biopharmaceutical and protein manufacturing simpler, more effective, and digital.
Biotechnology

2020

Unicorn Bio is building next-gen cell culture manufacturing systems to make the development and manufacture of living cell based products faster and more efficient. We enable our partners to seamlessly scale their innovations - from iPSC based cell therapies to cultivated meat - from the lab bench to commercial scale manufacturing. So that scale-up stresses are a thing of the past, and you can focus on creating transformative technologies to actively improving human and planetary health.
Biotechnology

2020

At Lextox, we provide drug, alcohol and DNA testing services for family law cases and child care proceedings. ISO 17025 UKAS Accredited Testing Laboratory (No. 7516), we follow strict quality assurance procedures to deliver legally defensible Analysis Results and Expert Reports which are accepted in every UK family court. Today we are trusted by more than 14,000 family law solicitors and local authorities to deliver a responsive service and reliable results. Lextox is a member of the SYNLAB Group, the leading medical diagnostic services provider in Europe. Find out more about our parent company, visit www.synlab.co.uk.
Biotechnology

2011

Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.
Artificial Intelligence
Medical
Biopharma
Healthcare
Biotechnology

2014

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer. This is the world's first IgE therapeutic to enter the clinic.
Biotechnology

2016

BioCule - The Nucleic Acid Quality Company BioCule is revolutionizing the way complex nucleic acid samples are analysed. THE ONE- AND TWO-DIMENSIONAL NUCLEIC ACID MICROELECTROPHORESIS SYSTEM FROM BIOCULE Single Use Precast Gel Cassettes Size distribution and relative amount detection of: -double-stranded DNA -single-stranded DNA -RNA*DNA hybrids -Crosslinked DNA -Damaged DNA and DNA repair Get confident about you complex nucleic acid samples: Complex PCR, cDNA synthesis, CHIP-sequencing DNA, NGS sample preparation (454FLX, MiSeq) Detection of DNA damage either in vivo or in biobank samples Additionally 1-D PAGE electrophoresis in 10 min
Biotechnology
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.
Biotechnology

2015

Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which with symptoms present from birth is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. Innoskel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is to improve the lives of patients living with rare bone disorders and to answer their unmet needs, keeping their voices at the heart of all they do.
Biotechnology

2020

OT4B (OxyTocin for Babies) est une start-up française, issue de l’alliance entre la recherche académique et une association de patients, dont l’ambition est de mettre à disposition le premier traitement précoce du syndrome de Prader-Willi (SPW). L’objectif de ce traitement par ocytocine est de modifier la trajectoire d’évolution des patients souffrant de cette maladie rare, en intervenant dès les premières semaines de vie. Le Professeur Maithé Tauber, experte de renommée mondiale et coordinateur du centre national de référence du syndrome au CHU de Toulouse, est à l’origine de cette approche thérapeutique innovante.
Biotechnology

2017

Let’s write the future of DNA. Ribbon Biolabs is a biotech start-up working on developing the next technological wave of error-proof DNA synthesis. With its approach, company is developing a cost-efficient platform to produce long and complex DNA molecules, thereby enabling a new generation of biopharmaceutical processes and other synthetic biology products. Our international and highly motivated team located in Vienna and Klosterneuburg is constantly looking for new talents who can join this exciting ride and take Ribbon Biolabs to the next level.
Biotechnology

2018

We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
Biotechnology

2011

Atley’s automated production module allows for a standardised and reproducible production of the pharmaceuticals used in Targeted Alpha Therapy, a promising treatment for disseminated cancer. The module will enhance clinical research in this field and is essential in order to enable the future treatment of cancer patients using this method. Targeted Alpha Therapy has the potential to improve and save millions of lives. For this to happen, Atley's technology is needed.
Biotechnology

2019

Norbite transforms plastic waste into sustainable goods by means of an insect-based biorefinery. The selected insect, Galleria mellonella, possess the extraordinary capacity to naturally digests plastic. Norbite took advantage of this feeding specificity of G. mellonella and has developed a proprietary vertical farming technology to enable the insects to perform at industrial scale. To produce sustainable goods, thus obtained larvae are bio-refined to get proteins, for food and feed; antimicrobial peptides (AMPs) - to fight multidrug resistant bacteria (MDR); elicitors – to reinforce natural plants’ defences and avoid the utilisation of pesticides; and even the dejections of the insects are used as biofertilizers, making this process a perfect example of circular economy.
Biotechnology

2020

We produce uniquely functional materials that are good for the planet. Our mission is to be the world-leading producer of advanced materials from algae and a driving force towards a circular and bio-based industry. We are the first company in the world to cultivate and sell diatom algae shells. We call the material Algica®. Algica® is a porous silica with unique light altering, absorptive and binding properties that are unmatched by synthetic materials. Algica® is today used as a top-performing and certified organic personal care ingredient. Products with Algica® has today been launched in the Nordics, US and Australia. Read more about the use of Algica in personal care applications at www.algica.com Algica® can also make silicon solar panels at least 4% more efficient and DSSC 38% more efficient. Each kg Algica® used in solar panels reduces C02 emissions with at leasts 200 tons according to WWF. The production is circular and we aim to make it as environmentally friendly as possible. The algae clean nutrient rich water from a land-based fish farm, and absorb CO2 and key nutrients that can be made into sustainable fish feed.
Biotechnology
Building accurate, accessible and affordable disease diagnostics to improve global health.
Biotechnology

2021

Manchester Biogel PeptiGel products are now part of Cell Guidance Systems. PeptiGel technology allows us to offer a family of high-quality peptide hydrogels, with a range of mechanical and functional properties, to enable you to find the most suitable materials for your application needs. PeptiGel hydrogels mimic the cell micro-environment and provide a natural physiological extracellular matrix that open up exciting new opportunities within the fields of 3D cell-culture, 3D bioprinting, regenerative medicine and medical devices to solve current healthcare challenges. Our technical support is available to help you realise your research ambition.
Biotechnology
PneumoWave is revolutionizing the response and management of Opioid Dependence and Mental Illness with a virtual-first approach for clinicians that harnesses the power of AI. We partner with those who are combatting the growing opioid crisis to deliver real-time physiological/behavioral data from multiple biosensors to screen, diagnose, monitor, and intervene patients at-risk for overdose.
Biotechnology

2018

Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia. Source LDPath provides an end-to-end clinical diagnostic service, from histopathology, including digital pathology and AI, through to molecular diagnostic services. Source LDPath already supports over 85 NHS Trusts and a comprehensive network of Private Healthcare clinics to expand their diagnostic capabilities, ensuring diagnostic results are delivered within clinically actionable timeframes. Source LDPath brings pioneering expertise in digital pathology and AI implementation, helping NHS pathology departments digitise their workflows for streamlined operations and greater diagnostic reporting capacity, tailoring integration touchpoints to the specific requirements of the Hospital or Trust. • Cellular and digital pathology wet laboratory processing • Reporting - access a pool of over 200 specialist consultant pathologists • MDM and Second Opinions • Digital Implementation Support with AI integration • Connectivity and LIMS integration with Source HIVE™ Source Genomics provides a broad portfolio of multi-omic services, delivering high-quality data in Genomics, Spatial Transcriptomics, Proteomics and Epigenomics. Market-leaders in Sanger Sequencing and Next-Generation Sequencing Services, Source Genomics delivers bespoke laboratory expertise to excel your project at rapid turnaround times. • Sanger Sequencing • NGS - WGS, WES, RNA-seq • Oxford Nanopore Sequencing • Olink proteomics • Optical Genome Mapping • 10x Genomics Visium • Bioinformatics • And more Contact us today at enquiries@sourcebioscience.com.
Biotechnology
Pathfinder Bio are at the forefront of transforming sustainable chemical manufacturing. Our mission is to develop high-performance, enzyme-based processes for the sustainable production of natural ingredients and fine chemicals. Our unique laboratory platform enables us to pioneer in the development of biocatalysts, setting new standards in sustainable chemical manufacturing for a happier planet. Leveraging our innovative platform, we focus on creating sustainable biotechnological processes that utilise enzymes for biomanufacturing products at scale. We are poised to revolutionise the world's transition to a sustainable global bioeconomy, embodying our commitment to eco-friendly practices and innovation in the field of biotechnology. We are continually looking for opportunities to exploit the unique advantages of our innovative technology platform to develop cost efficient and sustainable production processes for a variety of products across various industries. Contact us for more information.
Biotechnology

2022

Extracellular channels biology, digitalisation and biomanufacturing expertise to accelerate developments in biotech. We use our scale up experience and our deep insights into cellular behaviour to produce biomass for cultivated meat companies more efficiently. We're digitalising process development, pulling together huge quantities of data to make better decisions faster and at scale.
Biotechnology

2022

PentaBind is a VC-backed platform TechBio company using Generative Artificial Intelligence, Oligos (Aptamers) and Multiomics to design safer and better drug candidates for oncology. We are supported by Entrepreneur First VC, P4SY, Panacea Stars, Stevenage Bioscience Catalyst, Science Creates Accelerator, Science Entrepreneur Club, and KQ Labs. For more information or to join our mission: contact@PentaBind.com ***We are hiring Computational Biologists, Molecular Biologists, Protein and Data Engineers. Don't hesitate to reach out!***
Biotechnology

2021

We are an abitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only listed company on the LSE that is focusing on producing lab grown meat. This gives us access to funding to accelerate our progress.
Biotechnology

2019

We're pioneering the first online platform for life science data analysis. Our tools are intuitive and require no coding, making them accessible to all life scientists. We uphold the highest scientific standards and continuously refine our offerings based on customer feedback.
Biotechnology

2021

We're a Pharmatech company, leveraging a systems-modelling approach to develop the next generation of biologics. By leveraging a combination of AI and Physics, we've solved one of the key challenges of building large complex biophysical models. This presents us with a paradigm shift in our ability to take a rational approach to finding the optimal modalities of therapeutics to take forward into development, as we can infer previously unknown properties about these therapies and simulate all possible options to find the most efficacious, whilst retaining full mechanistic understanding of how and why they work. The 85-90% attrition rate at clinical trial for immuno-oncology therapies, which costs pharma $50billion+ year in failed trials, has been attributed to the lack of quality predictive pre-clinical models. We believe that a systems-based approach to in-silico modelling is the clear-cut solution to this problem. Our patent-pending technology reduces parameter uncertainty by up to 100x compared with existing biophysical or AI approaches, reducing data requirements by 10-20x. This is an order of magnitude shift, unlocking new possibilities for in-silico modelling of large-scale complex disease systems. This patent-pending innovation is at the core of Bioleap's mission. Our culture is one of open-ness. To challenge, to innovation, to research. Collaboration, breaking barriers, removing silos - with rigorous scientific intention and creative endeavour. We're taking on the greatest challenges facing biology. For that we're going to need the brightest minds - creating an ecosystem that provides the necessary environment to solve problems that have never been solved before.
Biotechnology

2022

Delta4 is driving the forefront of digital drug discovery and development. We leverage on a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs. Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effect.
Biotechnology

2019

reNEW Technologies - a circular enterprise - has developed a patented biothermal 2-step process to ferment and extract volatile fatty acids (VFA) and nutrients (NPK) from biosolids. This project was incubated within UTB Envirotec and is funded by the European Union's Horizon 2020 initiative.
Biotechnology

2019

Starting with a vision to truly take paternity testing to the general public, Complement Genomics has been bringing forward new DNA testing services since 2000. Working in areas as diverse as clinical trials and non-human DNA testing, the highly trusted company has considerable expertise in pharmacogenetics. Complement Genomics also provides COVID-19 testing for private clients and businesses. Operating from the Durham Genome Centre, Complement Genomics has developed different brands according to the market segment: - dadcheck®gold - DNA testing services for professionals, including solicitors, barristers, local authorities and social services - dadcheck®silver - a full range of DNA testing services for the general public, including paternity and other human relationships, for the determination of parentage, for immigration DNA tests or for DNA tests which are suitable for other legal purposes - Chxout - services designed to serve the non-human DNA testing market – for citizen scientists and professionals alike. Bat Species Identification | Bird Sexing | Bird Species Identification | Bird Parentage | DNA Barcoding of animals, plants and fungi - Geneblitz - designed to serve the CRO and pharmaceutical sector with genotyping and phenotyping for clinical trials - That DNA Company - an online value brand providing DNA testing services, primarily paternity tests, for the general public
Biotechnology

2000

Start your journey to the future with our Complete Cryopreservation Program. Take your chance at a second life. At Tomorrow Biostasis we offer the complete cryopreservation program in Europe so you can potentially be revived in the future to live an extended life. Our focus is on advancement and education in the space of medical biostasis. As the fastest growing cryopreservation company in the world and with over 150 members, our aim is to build a world where people can choose how long they want to live. We are optimistic about the future, the development of technology, and - most importantly - life. Our team is young and driven, consisting of doctors, engineers, and entrepreneurs. Join us today, and get ready for tomorrow.
Biotechnology

2020

UniqAir er en finsk cleantech virksomhed, der fremstiller og leverer specialudviklede systemer til den offentlige og private sektor. UniqAir’s system har verdens mest effektive sundhedsfiltre og er testet af Teknologisk Institut i Aarhus, VTT (Finlands Teknologiske Institut) og TTL (Finlands Arbejdssundhedsinstitut). UniqAir’s filtre fjerner 99.9% af synlige og usynlige partikler samt 100% af forurenende luftarter. UniqAir leverer effektiv og hurtig hjælp ved indeklimaproblemer i kommuner, regioner, social- og sundhedspleje, uddannelsesinstitutioner og virksomheder. Læs mere på www.uniqair.dk
Biotechnology

2012

Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases.
Biotechnology

2019

Siamo una società diversa, una società biotech, un modo di vivere, un'intera filosofia basata sul metodo scientifico e in cui le persone sono l'inizio e la fine del nostro entusiasmante progetto. Lavoriamo quotidianamente per loro sullo sviluppo delle migliori soluzioni tecnologiche, utilizzando l'estrazione di fitocomplessi dalla canapa per uso farmaceutico e cosmetico, l’estrazione di cellulose, nanocellulose e microfibrille di cellulosa per il mercato delle bioplastiche e l'estrazione dei derivati del carbonio per l'applicazione in diversi campi tra cui quello dell'ediliza e dell'automotive, il tutto per cercare di dare un apporto nel raggiungimento di una maggiore ecosostenibilità e una migliore qualità di vita. Professionisti in diversi settori (farmaceutico, edile, alimentare, ecc.) ci accompagnano lungo il nostro percorso e si fidano di noi, aiutandoci a ottenere e trasferire le tecniche più innovative in soluzioni per i nostri clienti. La nostra filosofia di lavoro è un modo di vivere che inizia con l'analisi delle esigenze specifiche dei diversi campi che trattiamo, prosegue con lo sviluppo delle soluzioni per venire incontro a tali esigenze e si conclude con i risultati prodotti per rivalutarle e migliorarle. Durante questo processo, effettuiamo ricerche seguendo un rigoroso metodo scientifico, pubblichiamo su importanti riviste scientifiche, testiamo, omologhiamo, produciamo e commercializziamo tutte le nostre innovazioni in Italia e all'estero, sempre con una chiara vocazione multidisciplinare. Ci comportiamo responsabilmente in ogni situazione e fissiamo standard elevati ai quali non veniamo mai meno. Questa condotta etica senza compromessi consente di mantenere l’efficienza dei nostri processi, l'integrità dei nostri prodotti, la sicurezza dei nostri collaboratori e il rispetto dell'ambiente in cui viviamo.
Biotechnology

2020

List of Biotechnology companies in Europe

Company Name

Location

Category

Employees

Website

Oxford, United Kingdom (UK)

Health and Medical
+1
Health and Medical, Science and Engineering

1000-5000

https://nanoporetech.com/

Paris, France

Health and Medical
+1
Health and Medical, Science and Engineering

50-100

https://www.pathoquest.com/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.semarion.com/

Loupiac-de-la-réole, France

Science and Engineering
Science and Engineering

20-30

https://toopi-organics.com/

Hamburg, Germany

Science and Engineering
Science and Engineering

30-50

https://www.traceless.eu/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://www.transinetx.com/

Pessac, France

Science and Engineering
Science and Engineering

100-150

https://treefrog.fr/

Amsterdam, The Netherlands

Science and Engineering
Science and Engineering

500-1000

https://www.uniqure.com/

Cambridge, United Kingdom (UK)

Health and Medical
+1
Health and Medical, Science and Engineering

50-100

http://www.cambridgebluegnome.com/

Oxford, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://www.cyanocapture.com/

Birmingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.coppertreeforensics.co.uk/

Vienna, Austria

Manufacturing and Industry
+2
Manufacturing and Industry, Health and Medical, Science and Engineering

10-20

https://aheadbio.com/

Prague, Czechia

Health and Medical
+1
Health and Medical, Science and Engineering

150-200

https://sotio.com/

Antwerp, Belgium

Manufacturing and Industry
+3
Manufacturing and Industry, Science and Engineering, Sales and Marketing, Agriculture and Livestock

20-30

http://www.wakati.co/

Hollandstrasse, Austria

Science and Engineering
Science and Engineering

20-30

https://www.fermify.org/

GEMENOS, France

Science and Engineering
Science and Engineering

2-10

https://xegen.fr/

Lund, Sweden

Science and Engineering
Science and Engineering

2-10

https://tigerq.com/

Granada, Spain

Science and Engineering
Science and Engineering

2-10

http://www.lentistem.com/

Linköping, Sweden

Science and Engineering
Science and Engineering

2-10

https://arguseye.se/

411, Sweden

Science and Engineering
Science and Engineering

2-10

https://nycteatechnologies.com/

Sheffield, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://www.unicornb.io/

Cardiff, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

https://lextox.co.uk/

Cambridge, United Kingdom (UK)

Information Technology
+2
Information Technology, Health and Medical, Science and Engineering

50-100

https://healx.ai/?utm_source=enterpriseleague.com

Hammersmith, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://epsilogen.com/

Reykjavik, Iceland

Science and Engineering
Science and Engineering

2-10

http://www.biocule.com

Dublin, Ireland

Science and Engineering
Science and Engineering

2-10

http://www.carricktherapeutics.com

Sophia Antipolis, France

Science and Engineering
Science and Engineering

2-10

http://www.innoskel.com

TOULOUSE, France

Science and Engineering
Science and Engineering

10-20

http://www.ot4b.com/

Vienna, Austria

Science and Engineering
Science and Engineering

20-30

http://www.ribbonbiolabs.com/

Copenhagen, Denmark

Science and Engineering
Science and Engineering

20-30

http://www.sniprbiome.com

Göteborg, Sweden

Science and Engineering
Science and Engineering

2-10

http://www.atley.com

Järfälla, Sweden

Science and Engineering
Science and Engineering

2-10

http://www.norbite.eu

Gothenburg, Sweden

Science and Engineering
Science and Engineering

10-20

http://www.swedishalgaefactory.com

Gothenburg, Sweden

Science and Engineering
Science and Engineering

2-10

https://www.videm.se/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://www.cellgs.com/items/defined-surfaces-and-ecms/peptigels.html

Eurocentral, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://www.pneumowave.com/

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

200-500

http://www.sourcebioscience.com/

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.pathfinderbio.co.uk/

Bristol, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://extracellular.com

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.pentabind.com/

Newcastle upon Tyne, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://3dbiotissues.com

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://metofico.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://bioleap.ai

Wien, Austria

Science and Engineering
Science and Engineering

2-10

http://www.delta4.ai

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.renewtech.co

Lanchester, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://compgeno.com

Berlin, Germany

Science and Engineering
Science and Engineering

10-20

https://www.tomorrow.bio

Solrød Strand, Denmark

Science and Engineering
Science and Engineering

10-20

https://www.uniqair.dk/

Gosselies, Belgium

Science and Engineering
Science and Engineering

10-20

http://aboleris-pharma.com

Roma, Italy

Science and Engineering
Science and Engineering

2-10

https://ghenesisbiotech.com/

400/480 results

Frequently asked questions

Updated 23 October 2026

What is Enterprise League?

Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.

Is it free to list my company?

Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.

How does verification work, and what does it cost?

Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.

Where does the company information come from?

Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.

How do I claim or correct my company’s profile?

Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.